Want to see SG:OTX full AI Analyst Report?
OTX Stock Chart & Stats
S$0.24
<S$0.01(2.38%)
At close: 4:00 PM EST
S$0.24
<S$0.01(2.38%)
Day’s Range― - ―
52-Week RangeS$0.20 - S$0.26
Previous CloseN/A
Volume900.00
Average Volume (3M)102.58K
Market Cap
S$30.27M
Enterprise ValueS$28.28M
Total Cash (Recent Filing)S$5.52M
Total Debt (Recent Filing)S$996.00K
Price to Earnings (P/E)20.8
Beta0.13
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield7.3%
Share Statistics
EPS (TTM)0.02
Shares Outstanding134,543,840
10 Day Avg. Volume45,910
30 Day Avg. Volume102,580
Financial Highlights & Ratios
PEG Ratio-0.61
Price to Book (P/B)1.82
Price to Sales (P/S)2.42
P/FCF Ratio11.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very High Gross MarginsSustained gross margins near 73%–80% indicate durable product/service economics and pricing power versus peers. High gross margins create a persistent buffer for operating leverage, supporting long-term profitability even if sales growth slows and enabling reinvestment or dividends.
Conservative Balance Sheet, Very Low LeverageExtremely low debt-to-equity (~0.06) and improving debt levels provide financial flexibility to fund capex, M&A or sustain payouts through cycles. A conservative capital structure lowers interest risk and supports durable shareholder returns and investment optionality over months.
Strong Cash Generation And High FCF ConversionOperating cash flow consistently covering net income and near-1.0 FCF conversion show high earnings quality and efficient conversion to cash. This underpins sustainable dividends and self-funded reinvestment capacity, strengthening resilience across a 2–6 month horizon.
Bears Say
Revenue Decline And Inconsistent GrowthA 3.1% revenue decline in 2026 after prior modest growth signals demand volatility or execution issues. Persistently uneven top-line growth limits scale benefits, complicates margin recovery, and makes medium‑term planning and capacity utilization less predictable.
Sharp Free Cash Flow Drop In 2026A roughly 23% fall in FCF suggests rising reinvestment needs or working-capital strain, reducing the cushion for dividends or opportunistic investments. Lower FCF momentum magnifies funding risk for discretionary initiatives and weakens margin for error over coming quarters.
Net Margin Erosion And Earnings VolatilityA material decline in net margin and historical earnings swings point to margin pressure or cost variability. That weakens predictability of returns on capital and complicates strategic allocation, increasing execution risk for management across the medium term.
Medinex Ltd. News
OTX FAQ
What was Medinex Ltd.’s price range in the past 12 months?
Medinex Ltd. lowest share price was S$0.20 and its highest was S$0.26 in the past 12 months.
What is Medinex Ltd.’s market cap?
Medinex Ltd.’s market cap is S$30.27M.
When is Medinex Ltd.’s upcoming earnings report date?
Medinex Ltd.’s upcoming earnings report date is Nov 12, 2026 which is in 134 days.
How were Medinex Ltd.’s earnings last quarter?
Medinex Ltd. released its earnings results on May 19, 2026. The company reported S$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by S$0.001.
Is Medinex Ltd. overvalued?
According to Wall Street analysts Medinex Ltd.’s price is currently Overvalued.
Does Medinex Ltd. pay dividends?
Medinex Ltd. pays a Quarterly dividend of S$0.008 which represents an annual dividend yield of 7.3%. See more information on Medinex Ltd. dividends here
What is Medinex Ltd.’s EPS estimate?
Medinex Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medinex Ltd. have?
Medinex Ltd. has 134,543,840 shares outstanding.
What happened to Medinex Ltd.’s price movement after its last earnings report?
Medinex Ltd. reported an EPS of S$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Medinex Ltd.?
Currently, no hedge funds are holding shares in SG:OTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medinex Ltd.
Medinex Limited, an investment holding company founded in Singapore in 2009, specializes in providing extensive professional support services, primarily catering to medical clinics across the country. The company's operations are divided into four main segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Services. Within its Medical Support Services division, Medinex assists with clinic establishment, streamlines license applications, delivers value-added solutions for the healthcare sector, offers comprehensive turnkey solutions, and provides strategic guidance to general practitioners and specialists on setting up their facilities. The Business Support Services segment extends its offerings beyond the medical field, supplying crucial administrative support such as accounting, tax agency, human resource management, and corporate secretarial services to a variety of sectors including food and beverage, retail, education, and beauty. Through its Pharmaceutical Services, Medinex manages the sourcing and supply of medical and pharmaceutical products to clinics. The Medical Services segment directly furnishes a range of clinical provisions, including diagnostic imaging and x-rays, pre-employment health examinations, vaccination programs, customized healthcare plans, and general health screenings. Furthermore, Medinex offers advisory and business management consultancy, call support services, data protection officer roles, and various training programs to its clients.
Technical Analysis
Hyphens Pharma International Ltd.
―
ISEC Healthcare Ltd
―
Asiamedic Limited
―
Medtecs International Corporation Ltd.
―
Alliance Healthcare Group Ltd.
―